PRESS RELEASE published on 08/25/2025 at 07:00, 1 year 2 months ago OSE Immunotherapeutics Proposes Governance Evolution and Reaffirms Strategic Priorities ahead of Annual General Meeting OSE Immunotherapeutics announces proposed governance evolution and reaffirms strategic priorities ahead of Annual General Meeting. Company focuses on Tedopi® and Lusvertikimab to unlock full potential Strategic Priorities Governance Evolution OSE Immunotherapeutics Lusvertikimab Tedopi
BRIEF published on 08/20/2025 at 18:05, 1 year 2 months ago OSE Immunotherapeutics Appoints Thomas Gidoin as CFO Chief Financial Officer Strategic Planning Biotech Financing OSE Immunotherapeutics Thomas Gidoin
BRIEF published on 08/20/2025 at 18:05, 1 year 2 months ago OSE Immunotherapeutics nomme Thomas Gidoin au poste de directeur financier Directeur Financier Planification Stratégique OSE Immunotherapeutics Financement Des Biotechnologies Thomas Gidoin
PRESS RELEASE published on 08/20/2025 at 18:00, 1 year 2 months ago OSE Immunotherapeutics Appoints Thomas Gidoin as Chief Financial Officer OSE Immunotherapeutics appoints Thomas Gidoin as Chief Financial Officer, bringing deep expertise in capital markets and financial strategy to the company. Gidoin succeeds Anne-Laure Autret-Cornet Chief Financial Officer Capital Markets Financial Strategy OSE Immunotherapeutics Thomas Gidoin
PRESS RELEASE published on 08/20/2025 at 18:00, 1 year 2 months ago OSE Immunotherapeutics nomme Thomas Gidoin au poste de Directeur Financier Nomination de Thomas Gidoin comme nouveau Directeur Financier chez OSE Immunotherapeutics. Il apporte 15 ans d'expertise internationale en finance et gouvernance Biotechnologie Finance Directeur Financier OSE Immunotherapeutics Thomas Gidoin
BRIEF published on 07/02/2025 at 08:05, 1 year 4 months ago OSE Immunotherapeutics Updates on Legal Proceedings Transparency Shareholder Meeting Legal Proceedings OSE Immunotherapeutics Nantes Commercial Court
BRIEF published on 07/02/2025 at 08:05, 1 year 4 months ago Mises à jour d'OSE Immunotherapeutics sur les procédures judiciaires Transparence Assemblée Des Actionnaires OSE Immunotherapeutics Procédures Judiciaires Tribunal De Commerce De Nantes
PRESS RELEASE published on 07/02/2025 at 08:00, 1 year 4 months ago OSE Immunotherapeutics met à jour l’information sur les procédures en cours OSE Immunotherapeutics provides an update on ongoing legal proceedings regarding shareholders' motions, confirms plans for annual shareholders' meeting on September 30, 2025 Shareholders Biotech Annual Meeting Legal Proceedings OSE Immunotherapeutics
PRESS RELEASE published on 07/02/2025 at 08:00, 1 year 4 months ago OSE Immunotherapeutics met à jour l’information sur les procédures en cours Mise à jour des procédures en cours par OSE Immunotherapeutics concernant une action en justice et la tenue de leur assemblée générale annuelle. Vision prospective de l'entreprise Biotechnologie Procédures En Cours Déclarations Prospectives Assemblée Générale Annuelle OSE Immunotherapeutics
BRIEF published on 06/20/2025 at 19:35, 1 year 4 months ago OSE Immunotherapeutics sécurise son Assemblée Générale Actionnaires Assemblée Générale Transparence OSE Immunotherapeutics Procédures Judiciaires
Published on 11/11/2026 at 00:40, 1 hour 4 minutes ago Upgraded Tunkillia MRE Validates Optimised Scoping Study
Published on 11/10/2026 at 23:30, 2 hours 14 minutes ago CCL Industries Announces 2026 Third Quarter Results
Published on 11/10/2026 at 23:00, 2 hours 44 minutes ago Vanta Announces Appointment of Chief Financial Officer and Corporate Secretary
Published on 11/10/2026 at 23:00, 2 hours 44 minutes ago Battery X Metals Announces Appointment of Chief Financial Officer and Corporate Secretary
Published on 11/10/2026 at 23:00, 2 hours 44 minutes ago Condor Agrees to Short Extension of Lucero Closing Payment with ELEMENT79 and Provides Huiñac Punta Drill Program Update
Published on 11/11/2026 at 00:15, 1 hour 29 minutes ago Lean Focus Launches Asia Pacific: Local Expertise. Global Impact.
Published on 11/10/2026 at 23:15, 2 hours 29 minutes ago GSMA MWC26 Doha welcomed over 10,000 attendees, as world-first ITU co-location puts MENA at the centre of global connectivity policy and innovation
Published on 11/10/2026 at 19:21, 6 hours 23 minutes ago ALTHEORA, Mäder Composites France et IPC s'associent pour donner une seconde vie aux matériaux composites
Published on 11/10/2026 at 18:00, 7 hours 44 minutes ago Déclaration du nombre total des droits de vote et du nombre d’actions au 31 octobre 2026
Published on 11/10/2026 at 17:45, 7 hours 59 minutes ago Damartex / Descriptif du programme de rachat d'actions
Published on 11/10/2026 at 17:35, 8 hours 9 minutes ago ENGIE - Déclaration du nombre total d'actions et de droits de vote au 31 octobre 2026
Published on 11/10/2026 at 17:31, 8 hours 13 minutes ago CNP Assurances SA annonce le succès de l’émission d’une obligation subordonnée Tier 2 de 500 M€.
